onasemnogene abeparvovec-brve
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for onasemnogene abeparvovec-brve, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM) [Phase 4]